Dietary serine and cystine attenuate the homocysteine-raising effect of dietary methionine: A randomized crossover trial in humans

American Journal of Clinical Nutrition

Volumn 80, Issue 3, 2004, Pages 674-679

  Verhoef, Petra ^a,b   Steenge, Gery R ^c   Boelsma, Esther ^c   Van Vliet, Trinette ^c   Olthof, Margreet R ^a,b   Katan, Martijn B ^a,b  

^a TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c TNO   (Netherlands)

Author keywords

Crossover study; Cysteine; Dietary protein; Homocysteine; Methionine; Serine

Indexed keywords

CYSTEINE; HOMOCYSTEINE; METHIONINE; SERINE; CYSTINE;

AMINO ACID BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; ATTENUATION; BODY WEIGHT; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; FOOD INTAKE; HUMAN; MALE; MEAL; MEASUREMENT; NORMAL HUMAN; POSTPRANDIAL STATE; PROTEIN RESTRICTION; RANDOMIZED CONTROLLED TRIAL; ADULT; ANALYSIS OF VARIANCE; BLOOD; CARDIOVASCULAR DISEASE; CROSSOVER PROCEDURE; DIET RESTRICTION; DRUG EFFECT; METABOLISM; PROTEIN INTAKE;

ADULT; ANALYSIS OF VARIANCE; AREA UNDER CURVE; CARDIOVASCULAR DISEASES; CROSS-OVER STUDIES; CYSTINE; DIETARY PROTEINS; FASTING; HOMOCYSTEINE; HUMANS; MALE; METHIONINE; SERINE;

EID: 4544271697     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/80.3.674     Document Type: Article

References (32)

1. Finkelstein JD, Martin JJ. Homocysteine. Int J Biochem Cell Biol 2000;32:385-9.
2. The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke. JAMA 2002;288:2015-22.
3. Klerk M, Verhoef P, Clarke R, et al. MTHFR 677C→T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 2002;288:2023-31.
4. Nelen WL. Hyperhomocysteinaemia and human reproduction. Clin Chem Lab Med 2001;39:758-63.
5. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346:476-83.
6. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med 1998;49:31-62.
7. Chambers JC, Obeid OA, Kooner JS. Physiological increments in plasma homocysteine induce vascular endothelial dysfunction in normal human subjects. Arterioscler Thromb Vasc Biol 1999;19:2922-7.
8. Ubbink JB, Vermaak WJ, van der Merwe A, Becker PJ. The effect of blood sample aging and food consumption on plasma total homocysteine levels. Clin Chim Acta 1992;207:119-28.
9. Guttormsen AB, Schneede J, Fiskerstrand T, Ueland PM, Refsum HM. Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects. J Nutr 1994;124:1934-41.
10. Di Buono M, Wykes LJ, Ball RO, Pencharz PB. Dietary cysteine reduces methionine requirement in men. Am J Clin Nutr 2001;74:761-6.
11. Finkelstein JD, Martin JJ, Harris BJ. Methionine metabolism in mammals. The methionine-sparing effect of cystine. J Biol Chem 1988;263:11750-4.
12. Aguilar TS. Studies in vivo on the methionine-sparing effect of cysteine in rats. Arch Latinoam Nutr 1982;32:130-47.
13. Stead LM, Brosnan ME, Brosnan JT. Characterization of homocysteine metabolism in the rat liver. Biochem J 2000;350:685-92.
14. Benevenga NJ, Harper AE. Effect of glycine and serine on methionine metabolism in rats fed diets high in methionine. J Nutr 1970;100:1205-14.
15. Girard-Globa A, Robin P, Forestier M. Long-term adaptation of weanling rats to high dietary levels of methionine and serine. J Nutr 1972;102:209-17.
16. Fettman MJ, Valerius KD, Ogilvie GK, et al. Effects of dietary cysteine on blood sulfur amino acid, glutathione, and malondialdehyde concentrations in cats. Am J Vet Res 1999;60:328-33.
17. Ventura P, Panini R, Abbati G, Marchetti G, Salvioli G. Urinary and plasma homocysteine and cysteine levels during prolonged oral N-acetylcysteine therapy. Pharmacology 2003;68:105-14.
18. Friedman AN, Bostom AG, Laliberty P, Selhub J, Shemin D. The effect of N-acetylcysteine on plasma total homocysteine levels in hemodialysis: a randomized, controlled study. Am J Kidney Dis 2003;41:442-6.
19. Miner SE, Cole DE, Evrovski J, et al. N-acetylcysteine neither lowers plasma homocysteine concentrations nor improves brachial artery endothelial function in cardiac transplant patients. Can J Cardiol 2003;18:503-7.
20. Raijmakers MT, Schilders GW, Roes EM, et al. N-acetylcysteine improves the disturbed redox balance after methionine loading. Clin Sci (Lond) 2003;105:173-80.
21. Mann NJ, Li D, Sinclair AJ, et al. The effect of diet on plasma homocysteine concentrations in healthy male subjects. Eur J Clin Nutr 1999;53:895-9.
22. Verhoef P, Stampfer MJ, Buring JE, et al. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Am J Epidemiol 1996;143:845-59.
23. Ubbink JB, Vermaak WJH, Bissbort S. Rapid HPLC assay for total homocysteine levels in human serum. J Chromatogr 1991;565:441-6.
24. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993;39:1764-79.
25. Schrijver J, Speek AJ, Schreurs WH. Semi-automated fluorometric determination of pyridoxal-5′-phosphate (vitamin B6) in whole blood by high-performance liquid chromatography (HPLC). Int J Vitam Nutr Res 1981;51:216-22.
26. Dicker-Brown A, Fonseca VA, Fink LM, Kern PA. The effect of glucose and insulin on activity of methylene tetrahydrofolate reductase and cystathionine-beta-synthase: studies in hepatocytes. Atherosclerosis 2001;158:297-301.
27. McCarty MF. Insulin secretion as a potential determinant of homocysteine levels. Med Hypotheses 2000;55:454-5.
28. Khan MA, Gannon MC, Nuttall FQ. Glucose appearance rate following protein ingestion in normal subjects. J Am Coll Nutr 1992;11:701-6.
29. Ueland PM, Refsum H, Beresford SAA, Vollset SE. The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr 2000;72:324-32.
30. Clarke R, Armitage J. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements. Semin Thromb Haemost 2000;26:341-8.
31. Graham IH, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997;277:1775-81.
32. Chambers JC, McGregor A, Jean MJ, Obeid OA, Kooner JS. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy. Circulation 1999;99:1156-60.